KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
Earnings for KemPharm (KMPH)
Earnings in 2022 (TTM): -$41.91 M
According to KemPharm's latest financial reports the company's current earnings (TTM) are -$41.91 M. In 2021 the company made an earning of -$8.14 M a decrease over its 2020 earnings that were of -$5.84 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for KemPharm from 2014 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$41.91 M | 415.01% |
| 2021 | -$8.14 M | 39.34% |
| 2020 | -$5.84 M | -67.62% |
| 2019 | -$18.03 M | -63.58% |
| 2018 | -$49.51 M | 54.69% |
| 2017 | -$32.01 M | 224.53% |
| 2016 | -$9.87 M | -79.67% |
| 2015 | -$48.51 M | 122.91% |
| 2014 | -$21.77 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | -$49.27 M | 17.58% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $0.29 B | -811.03% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $19.87 M | -147.43% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$13.05 M | -68.86% | 🇺🇸 USA |